文献速递脊柱脊髓外科神经肿瘤

脊髓脑膜瘤的基因组分析:与组织病理学分级的关联

Genomic analysis of spinal meningiomas: correlation with histopathological grade.
PubMed 文献 · J Neurosurg Spine · 2023-08-25

该研究评估了2002至2022年间手术治疗的94例脊髓脑膜瘤,其中81例(86%)为WHO 1级、13例(14%)为WHO 2级;57例有全基因组DNA拷贝数谱,44例(77%)显示22q/NF2缺失,高风险拷贝数改变少见;9例可评估的WHO 2级肿瘤中6例被重新分类为整合分级1级。作者认为脊髓脑膜瘤生物学行为惰性,这对完全Simpson I级切除的必要性及避免术后辅助治疗有启示。

要点

  • 94例脊髓脑膜瘤中WHO 1级81例(86%)、WHO 2级13例(14%)。
  • 57例有拷贝数谱的肿瘤中44例(77%)显示22q/NF2缺失。
  • 9例可评估的WHO 2级肿瘤中6例被重新分类为整合分级1级。

核心结论

  • 分析提示脊髓脑膜瘤生物学行为总体惰性,这得到其良性整合分级的支持。
  • 这些发现对完全Simpson I级切除的必要性及术后避免辅助治疗有启示。

研究设计与样本

  • 单中心研究,评估2002至2022年间手术治疗的94例脊髓脑膜瘤。
  • 记录WHO分级、核分裂指数、非典型特征及MIB-1指数,57例有全基因组DNA拷贝数谱。

主要发现

  • 队列WHO分级为1级81例(86%)、2级13例(14%)。
  • 有拷贝数谱的57例中44例(77%)显示22q/NF2缺失。
  • 常见高风险拷贝数改变缺失,包括1p、3p、4p/q、6p/q、10p/q、14q、18p/q、19p/q缺失及9p上CDKN2A局灶缺失。
  • 有拷贝数谱的9例WHO 2级肿瘤中6例被重新分类为低风险谱(整合分级1级)。

临床怎么用

  • 作者认为这些发现对完全Simpson I级切除的必要性及术后避免辅助治疗有启示。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spinal meningiomas are one of the most common primary intradural tumors of the adult spine. Spinal meningiomas typically have a benign course with low rates of recurrence. Recent advances in genomic profiling have provided valuable information on meningioma biology and natural history, but these studies have focused primarily on cranial meningiomas. Chromosomal copy number analysis of meningiomas has been shown to be a valuable molecular profiling technique for distinguishing benign from aggressive tumors. The Integrated Grade for Meningioma is a novel grading scheme that uses mitotic index and copy-number profile to identify aggressive tumors at high risk for recurrence. The integrated grade has been shown to be a better predictor of tumor behavior than WHO grade alone. The objective of this study was to evaluate the chromosomal copy-number profile of spinal meningiomas, and to correlate these findings with the assigned WHO grades. METHODS: The authors evaluated 94 spinal meningiomas treated surgically at their institution between 2002 and 2022. The histopathological results including WHO grade, mitotic index, presence of atypical features, and MIB-1 index were recorded. Chromosomal copy number as determined by institutional whole-genome DNA copy-number profiling was available for 57 tumors. RESULTS: The WHO grades of the cohort consisted of 81 (86%) WHO grade 1 tumors and 13 (14%) WHO grade 2 tumors. In tumors for which copy-number profiling was available, 44 (77%) of 57 demonstrated loss of 22q/NF2. Notably absent were frequent high-risk copy number alterations including loss of 1p, 3p, 4p/q, 6p/q, 10p/q, 14q, 18p/q, 19p/q, and focal loss of CDKN2A on 9p. Of the 9 WHO grade 2 tumors for which copy-number profiling was available, 6 tumors were reclassified to a lower risk profile (integrated grade 1). CONCLUSIONS: This analysis suggests that spinal meningiomas exhibit overwhelmingly indolent biology, as supported by their benign integrated grade. These findings have implications in the surgical management of these patients in relation to the need for complete Simpson grade I resection, as well as the potential avoidance of adjuvant therapy following surgery in the setting of otherwise frequently benign pathology.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Driver J, Santagata S, Bi WL, et al. Genomic analysis of spinal meningiomas: correlation with histopathological grade. J Neurosurg Spine. 2023. PMID: 37728381. doi:10.3171/2023.6.SPINE23425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。